Viewing Study NCT03374358


Ignite Creation Date: 2025-12-25 @ 12:26 AM
Ignite Modification Date: 2026-02-23 @ 9:21 PM
Study NCT ID: NCT03374358
Status: COMPLETED
Last Update Posted: 2021-09-05
First Post: 2017-12-02
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Effect on Liver Fat and Metabolic Parameters When Switching a Protease Inhibitor or Efavirenz to Raltegravir
Sponsor: Helsinki University Central Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV Seropositivity View
None Metabolic Syndrome View
None Fatty Liver View
Keywords: